Ditchcarbon
  • Customers
  1. Organizations
  2. Chembio Diagnostics, Inc.
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 5 months ago

Chembio Diagnostics, Inc.

Company website

Chembio Diagnostics, Inc., a leading player in the diagnostics industry, is headquartered in the United States and operates across various regions globally. Founded in 1985, the company has established itself as a pioneer in the development of innovative point-of-care testing solutions, particularly in infectious disease diagnostics. Chembio's core products include rapid tests for diseases such as HIV, syphilis, and malaria, distinguished by their accuracy and speed. The company’s unique dual-path technology enhances test performance, setting it apart in a competitive market. With a commitment to improving patient outcomes, Chembio has achieved significant milestones, including partnerships with global health organisations. Recognised for its contributions to public health, Chembio Diagnostics continues to strengthen its market position through ongoing research and development, ensuring it remains at the forefront of diagnostic innovation.

DitchCarbon Score

How does Chembio Diagnostics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

28

Industry Benchmark

Chembio Diagnostics, Inc.'s score of 25 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.

30%

Let us know if this data was useful to you

Chembio Diagnostics, Inc.'s reported carbon emissions

Chembio Diagnostics, Inc., headquartered in the US, currently does not have specific carbon emissions data available for recent years, as indicated by the absence of reported figures. The company is a current subsidiary of Biosynex SA, which may influence its climate commitments and reporting practices. As of now, Chembio has not established any documented reduction targets or initiatives, nor does it participate in the Science Based Targets initiative (SBTi). This lack of specific commitments suggests that the company may still be in the early stages of developing a comprehensive climate strategy. Given the context of the diagnostics industry, it is essential for Chembio to align with broader environmental goals and industry standards to enhance its sustainability profile. The absence of emissions data and reduction targets highlights an opportunity for Chembio to adopt more robust climate commitments in the future.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Chembio Diagnostics, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Chembio Diagnostics, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Chembio Diagnostics, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Dexcom

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 2 days ago

Guangzhou Wondfo Biotech Co.,Ltd

CN
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 13 days ago

WonderFi Technologies Inc.

CA
•
Financial intermediation services, except insurance and pension funding services (65)
Updated 13 days ago

SD Biosensor, Inc

KR
•
Pharmaceutical Preparation Manufacturing
Updated 13 days ago

Johnson And Johnson

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 days ago

ARKRAY, Inc.

JP
•
Other non-ferrous metal products
Updated 13 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250808.1
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy